Speciality: Endocrinology
Description:
A warm welcome to all the medical professionals in this interesting session on the benefits of influenza vaccination in the high-risk populations of diabetes.
Influenza is responsible for multiple deaths and about 20 to 30% of the deaths occurring annually are observed in children depicting the poor condition of controlling influenza in children. The virus is present globally but is not that powerful to create an epidemic.
Among people with diabetes and chronic lung disease like COPD influenza causes severe impacts and flu vaccination has been shown to be associated with reduced hospitalizations from a worsening of their chronic condition.
Patients with Type 2 diabetes have an increased risk for a severe course of influenza virus infection. Influenza vaccination can safely and effectively reduce all-cause mortality and cardiovascular death in such patients. It is more effective when using higher-dose and quadrivalent vaccines.
Therefore, get an overall knowledge regarding the benefits of influenza vaccination in high-risk populations of diabetes. Listen to the webinar, grab the knowledge that is shared, and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.
2.
Relationship-building key to addressing oncologist shortages in rural care
3.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
4.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
5.
Prostate cancer therapies: AI-based image analysis detects early organ damage
1.
Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice
2.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
3.
Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment
4.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
5.
Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation